Protein and DNA nanoparticulate multiantigenic vaccines against H. pylori: In vivo evaluation

Lara Figueiredo*, Cecilia C. R. Calado, António J. Almeida, Lídia M. D. Gonçalves

*Corresponding author for this work

    Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

    6 Citations (Scopus)

    Abstract

    Immunisation against H. pylori is an attractive option for antibiotic resistance and reinfection situations. Strain genetic heterogeneity, and low immunogenicity of protein antigens and DNA alone are nonetheless obstacles to this approach. We developed multigenic H. pylori DNA-nanoparticle and protein-nanoparticle vaccines based on pathogenic relevance. Six antigens were chosen for the vaccine construction: CagA, VacA, HpaA, UreB, HomB and GroEL. Different combinations of CS/DS and CS/Alg /TPP nanoparticles with DNA and chimeric proteins were produced as vaccine systems. Immune responses were evaluated after i.m. and oral immunisation of BALB/c mice. Oral vaccination successfully stimulated mucosal immunity while i.m. immunisation efficiently elicited a more equilibrated cellular/humoral immune response.
    Original languageEnglish
    Title of host publication2012 IEEE 2nd Portuguese Meeting in Bioengineering, ENBENG 2012
    DOIs
    Publication statusPublished - 2012
    Event2012 IEEE 2nd Portuguese Meeting in Bioengineering, ENBENG 2012 - Coimbra, Portugal
    Duration: 23 Feb 201225 Feb 2012

    Publication series

    Name2012 IEEE 2nd Portuguese Meeting in Bioengineering, ENBENG 2012

    Conference

    Conference2012 IEEE 2nd Portuguese Meeting in Bioengineering, ENBENG 2012
    Country/TerritoryPortugal
    CityCoimbra
    Period23/02/1225/02/12

    Keywords

    • Chitosan
    • Helicobacter pylori
    • Nanoparticles
    • Vaccine

    Fingerprint

    Dive into the research topics of 'Protein and DNA nanoparticulate multiantigenic vaccines against H. pylori: In vivo evaluation'. Together they form a unique fingerprint.

    Cite this